Sarcoidosis and Cosmetic Surgery: Lupus Pernio, Scar and Tattoo Sarcoid, Filler Granulomas, the Nose, Steroids, and Heart Screening

She is 46 and has known about her sarcoidosis for nine years. It was found the way it often is: a routine chest X-ray showed swollen lymph nodes in the middle of her chest, a bronchoscopy biopsy came back with the tiny clusters of immune cells called granulomas, and after a year of prednisone her lungs settled down. She has felt well for a long time. What brings her to a cosmetic consultation is her face. A thin scar on her chin from a childhood fall has turned raised and reddish purple over the last two years. The cheek filler she had placed three years ago has developed firm, slightly tender bumps. And the skin over the sides of her nose has thickened into a dusky, puffy plaque that makeup no longer hides. She wants the bumps gone, the scar revised, and, if possible, some help with the nose. On the intake form, under medical history, she writes "sarcoidosis, in remission."

Every one of her cosmetic complaints may be the sarcoidosis itself. That is the central point of this piece. Sarcoidosis is not just a lung disease that happens to sit in the background of a cosmetic plan. It is a disease that has a strange preference for the exact places cosmetic medicine works: scars, tattoos, injected material, and the skin of the central face. It also involves the eyes, the salivary glands, the nose and sinuses, the calcium balance of the body, and in a meaningful minority of patients, the electrical system of the heart. None of this means she cannot be helped. It means the first appointment should probably be with a biopsy needle and her sarcoidosis doctor, not with a scalpel or more filler.

Sarcoidosis and cosmetic surgery: what the disease is and why the skin matters

The short answer: sarcoidosis is an inflammatory disease in which the immune system forms small clusters of cells called granulomas in one or more organs, most often the lungs and lymph nodes, and roughly a quarter to a third of patients have skin involvement, which is why it so often walks into dermatology and plastic surgery offices disguised as a cosmetic problem.

Nobody knows exactly what triggers sarcoidosis. The leading theory is that a genetically susceptible immune system overreacts to something it encounters, possibly an environmental or microbial antigen, and walls it off with granulomas that never quite resolve. The disease can involve almost any organ. The lungs and the lymph nodes in the chest are affected in the large majority of patients. The skin, the eyes, the liver, the nerves, the joints, the salivary glands, and the heart follow in varying proportions. Some people have one episode that resolves on its own within two to five years. Others, often estimated at somewhere between 10 and 30 percent, develop chronic disease that needs long-term treatment.

In the United States, sarcoidosis is diagnosed more often in women than men, usually between ages 20 and 60, and it is notably more common and often more severe in Black Americans. A widely cited Detroit study estimated a lifetime risk of about 2.4 percent for Black Americans compared with under 1 percent for white Americans. That matters for cosmetic practice in two ways. First, the patients most likely to have sarcoidosis are also patients for whom keloids, pigment changes, and scarring are already part of the conversation, so a raised scar may be blamed on keloid tendency when it is actually sarcoid. Second, chronic skin disease on the face in this group, particularly the form called lupus pernio, can be disfiguring and is often undertreated.

The skin signs fall into two broad groups. Specific lesions contain sarcoid granulomas on biopsy:

• Papules and plaques. Small, firm, skin-colored, reddish brown, or purple bumps, often around the nose, eyelids, lips, and hairline, or larger plaques on the limbs and back.
• Lupus pernio. Dusky red to violet, swollen, shiny plaques on the nose, cheeks, ears, and lips. Despite the name, it has nothing to do with lupus. It is strongly linked to chronic disease, to involvement of the nasal lining and sinuses, and to bone changes, and it is one of the hardest forms to treat.
• Scar sarcoidosis. Old scars that become red, raised, firm, or purple, sometimes years or decades after the original wound. This can be the first sign of the disease or a sign that quiet disease has become active again.
• Tattoo sarcoidosis. Granulomas that form within tattoo ink, often in one color, making the design swell and harden.
• Sarcoidosis at filler or foreign material sites. Granulomas that form around injected fillers, permanent implants, or other material in the skin.

The second group, nonspecific lesions, are reactions to the disease rather than granulomas themselves. The most common is erythema nodosum, tender red nodules on the shins. Together with swollen chest lymph nodes, fever, and ankle arthritis, it forms Löfgren syndrome, an acute presentation that usually resolves on its own within a year or two. A patient in the middle of Löfgren syndrome is having an active systemic inflammatory illness and is not a candidate for elective surgery, however good the odds of remission.

The connection to cosmetic surgery is that sarcoid granulomas seem to gather in places where the skin has already been injured or contains foreign material. Dermatologists describe this tendency as similar to the Koebner phenomenon seen in psoriasis and vitiligo, which the site has covered in the posts on psoriasis and cosmetic surgery and vitiligo and cosmetic surgery. Old scars, tattoo ink, filler, injection points, and new incisions can all become sites of disease. That is not common enough to forbid procedures. It is common enough that a patient with active skin sarcoidosis should hear about it before agreeing to a new scar.

The lump that might be the disease: filler granulomas, tattoo sarcoid, and scars that change

The short answer: a new firm bump in an old scar, a tattoo, or a filler site in someone with known or suspected sarcoidosis should be biopsied before it is treated as a routine filler nodule or keloid, because the treatment for sarcoid granulomas is different and the bump may be the first sign that the disease is active elsewhere.

Late filler bumps are a familiar problem. The site's piece on delayed filler nodules walks through the usual suspects: product placed too superficially, low-grade infection or biofilm, and inflammatory reactions to the filler itself. Sarcoidosis adds another possibility. Case reports and small series in dermatology journals describe sarcoid granulomas forming around hyaluronic acid, poly-L-lactic acid, calcium hydroxylapatite, silicone, and polymethylmethacrylate. In some of those patients, the filler reaction was the first sign of sarcoidosis anyone noticed, and a chest scan done afterward found swollen lymph nodes or lung involvement. In others, filler sites flared when known disease became active, or when patients started drugs known to trigger sarcoid-like reactions, such as interferon or some cancer immunotherapies.

The practical consequence is that a bump at a filler site is not one diagnosis. A firm, tender, slightly purple nodule that appears months or years after injection could be a foreign-body granuloma, which is the body walling off the product, or a sarcoid granuloma, which is the disease using the product as a scaffold. Under the microscope, a pathologist can often tell the difference and can use polarized light to see certain foreign materials. A culture can look for infection. A dermatologist who suspects sarcoidosis will usually ask for a chest X-ray and blood work too.

Why it matters: treatment diverges.

• Hyaluronic acid nodules from ordinary causes are often dissolved with hyaluronidase, as covered in the piece on whether you can dissolve dermal filler. In sarcoid granulomas around hyaluronic acid, dissolving the product can help, but the granuloma may persist, and treating the underlying disease may matter more.
• Biostimulatory and permanent products cannot be dissolved. The difference between product types is laid out in the piece on biostimulatory fillers vs hyaluronic acid, and the risks of the permanent end of the spectrum in the piece on permanent lip augmentation. Sarcoid granulomas around permanent fillers are often treated with steroid injections into the nodules, hydroxychloroquine, methotrexate, or other systemic drugs, and sometimes surgical removal, which can leave its own scars.
• Tattoo sarcoidosis can calm with treatment of the disease. Laser tattoo removal has been reported both to help and, in some cases, to flare granulomas as ink particles are broken up and redistributed. The general scarring risks are covered in the piece on laser tattoo removal; in a patient with tattoo sarcoid, the laser decision belongs to a dermatologist who knows the disease.

Scars deserve the same caution. A scar that was flat and pale for years and then becomes raised, firm, and violet is not acting like a keloid, which usually grows within months of the injury. That change in an old scar should prompt a biopsy. Revising it surgically without a diagnosis risks cutting out a sarcoid plaque only to watch the new scar fill in with granulomas a few months later. If biopsy confirms scar sarcoidosis, the first step is usually to treat the disease, often with steroid injections into the scar or with systemic therapy, and to revisit revision only when the scar has been quiet for some time. The general principles of scar care after plastic surgery still apply once the disease is controlled.

There is also the question of whether fillers should be placed at all in someone with sarcoidosis. There is no consensus statement forbidding it. Many dermatologists are comfortable placing a modest amount of dissolvable hyaluronic acid filler in a patient whose disease has been quiet for a long time, after an honest discussion, and are much more reluctant to place biostimulatory or permanent products that cannot be removed if a granuloma forms. Patients with active skin disease, a history of granulomas at prior filler sites, or a history of tattoo or scar sarcoid are poor candidates for any filler until the disease is controlled.

The face itself: lupus pernio, the nose, the eyes, and the salivary glands

The short answer: when sarcoidosis involves the central face, the cosmetic problem and the disease are the same thing, so the first job is to bring the disease under control with medical treatment, and surgery, lasers, and fillers on an affected nose, eyelid, or cheek come later, if at all, and only in coordination with the physician treating the sarcoidosis.

Lupus pernio and the nose. Lupus pernio is the facial lesion patients find hardest to live with. The nose thickens and turns dusky purple, the nostril rims swell, and the skin over the cheeks can look persistently flushed and bumpy. It is often confused with rosacea, and a long-standing case can look a lot like the bulbous nose discussed in the piece on rhinophyma. The distinction matters because rhinophyma is often treated with sculpting by laser or blade, while lupus pernio is a sign of granulomas that may extend into the nasal lining, the cartilage, and the bones beneath.

Sarcoidosis inside the nose and sinuses causes crusting, congestion, nosebleeds, and loss of smell. In more advanced cases, granulomas damage the septum, leading to septal perforation and, occasionally, a collapse of the bridge that produces a saddle nose. The site's piece on septal perforation and saddle nose lists sarcoidosis among the systemic causes that need to be ruled out before anyone plans a repair. A patient who wants a cosmetic or functional nose operation and has unexplained crusting, nosebleeds, or a small perforation should be evaluated by an ear, nose, and throat specialist before surgery is scheduled.

Can lupus pernio be treated with surgery or lasers? Medical treatment comes first and does most of the work. Dermatology literature reports that hydroxychloroquine, methotrexate, and especially the TNF inhibitor infliximab can produce real improvement in lupus pernio, sometimes after years of failed steroid treatment. Once the disease is controlled, small reports describe pulsed dye laser to reduce redness and ablative laser or surgical debulking to improve nasal shape, with variable results and a real risk of recurrence. Rhinoplasty on a nose with active sarcoid granulomas in the lining and cartilage is a high-risk operation: wound healing is unpredictable, and the disease may progress regardless of what the surgeon does. The general considerations in the piece on functional rhinoplasty still apply, but the threshold for operating is higher, and the timeline is set by the disease, not the calendar.

The eyes and eyelids. Sarcoidosis inflames the eyes in a significant share of patients. The most common problem is uveitis, inflammation inside the eye, which can cause redness, light sensitivity, blurred vision, and floaters, and which can threaten vision if untreated. Granulomas can also enlarge the tear glands and cause dry eye. Patients with sarcoidosis are often advised to have a yearly eye exam for this reason. For anyone considering eyelid surgery, that history matters. Dry eye can worsen after blepharoplasty, a problem explained in the piece on dry eye after eyelid surgery, and a patient whose tear glands are already involved starts closer to the edge. A puffy upper or outer eyelid may be an enlarged tear gland rather than fat or extra skin, and removing it as part of a cosmetic blepharoplasty would be a mistake. Eyelid papules from sarcoidosis also look a lot like the benign bumps described in the piece on xanthelasma and syringoma, which is one more reason to biopsy a lesion before treating it.

The salivary glands and facial nerve. Sarcoidosis can enlarge the parotid glands, giving a wide, puffy look at the jaw angle. The site's piece on swollen parotid glands and a wide jaw explains why a wide jaw is not always muscle and should not be treated with masseter Botox until the gland has been examined. In a rare form called Heerfordt syndrome, parotid swelling comes with uveitis, fever, and weakness of the facial nerve. Sudden one-sided facial weakness in a sarcoidosis patient is a neurological question first, not a cosmetic one.

Lips. Persistent firm swelling of the lip can come from granulomatous diseases including sarcoidosis, as discussed in the piece on lip reduction surgery. Reducing a lip that is swollen because of granulomas, without treating the disease, risks a lip that swells again and a scar that may itself become involved.

Before the operation: lungs, heart rhythm, calcium, and the sarcoidosis team

The short answer: the most dangerous parts of sarcoidosis for an elective operation are the ones the patient cannot see, so a safe plan starts with up-to-date lung testing, a deliberate screen for heart involvement, a calcium check, and a written note from the sarcoidosis specialist saying the disease is stable enough for elective surgery.

Lungs. Most patients have some lung or chest lymph node involvement, and while many recover fully, a minority develop scarring, stiff lungs, and reduced oxygen transfer. Pulmonary function tests, including a measure of how well oxygen crosses into the blood, show the anesthesia team where the patient stands. Advanced fibrotic sarcoidosis can lead to pulmonary hypertension, high pressure in the arteries of the lungs, which raises anesthesia risk considerably. A patient with significant lung scarring or pulmonary hypertension is not a candidate for long, combined cosmetic operations, and the type and setting of anesthesia need careful thought. The tradeoffs are explained in the piece on choosing anesthesia and the operative plan.

Heart. Cardiac sarcoidosis is the reason this disease deserves respect before any operation. Granulomas in the heart muscle can disrupt the electrical system, causing heart block, where signals between the upper and lower chambers slow or stop, and dangerous ventricular arrhythmias. Clinically obvious heart involvement is found in roughly 5 percent of patients, but imaging and autopsy studies suggest it is present in a much larger share, perhaps a quarter, often without symptoms. The Heart Rhythm Society and other cardiology groups recommend that people with sarcoidosis be screened for heart involvement with a careful symptom history and an electrocardiogram, with an echocardiogram often added, and that anyone with abnormal results or symptoms such as palpitations, fainting, or unexplained shortness of breath be evaluated further with cardiac MRI or PET imaging. A patient who has never had that screening should have it before elective surgery. A patient who already has a pacemaker or defibrillator for cardiac sarcoidosis needs device planning, as described in the piece on pacemakers and defibrillators before cosmetic surgery, because electrocautery and some energy devices can interfere with those devices.

Calcium and kidneys. Sarcoid granulomas can convert vitamin D into its active form on their own, outside the body's normal controls, which raises calcium levels in the blood and urine. That leads to kidney stones and, over time, kidney damage. Two practical points follow. First, a calcium level and kidney function test belong in the preoperative workup. Second, patients should not start high-dose vitamin D supplements, sometimes recommended for bone or wound healing, without checking with their sarcoidosis doctor. Patients whose kidneys have already been affected can look to the site's piece on chronic kidney disease before cosmetic surgery for what that adds to the plan, including caution with anti-inflammatory painkillers.

Disease activity. The American Thoracic Society's 2020 guideline on diagnosing sarcoidosis emphasizes that the diagnosis rests on a compatible clinical picture, a biopsy showing granulomas where possible, and the exclusion of other causes such as tuberculosis and fungal infection. For cosmetic purposes, the related question is whether the disease is active right now. That is a judgment for the pulmonologist, dermatologist, or rheumatologist following the patient, based on symptoms, imaging, lung tests, blood work, and skin and eye exams. A reasonable rule for elective cosmetic surgery is to wait until the disease has been stable for months, on a steady treatment plan or none at all, with no recent flares, no new organ involvement, and no planned changes in medication. The general autoimmune framework in the site's piece on cosmetic surgery with autoimmune disease applies here as well.

Steroids, methotrexate, and biologics: the medication picture around surgery

The short answer: most sarcoidosis medications affect healing or infection risk, so they need a plan worked out in advance between the sarcoidosis doctor, the surgeon, and the anesthesia team, and patients on long-term steroids may need extra steroid coverage on the day of surgery because their own adrenal glands may not respond normally to stress.

The European Respiratory Society's 2021 treatment guideline lays out the usual ladder. Corticosteroids, most often prednisone, are the first choice when treatment is needed. Methotrexate is the most common second-line drug, used to reduce steroid doses or when steroids fail. Hydroxychloroquine is used especially for skin disease. TNF inhibitors, mainly infliximab and adalimumab, are reserved for refractory disease, particularly lupus pernio, heart, and nervous system involvement. Very few of these carry an FDA label specifically for sarcoidosis; most use is off-label, based on trials and expert consensus. Each has implications for surgery.

"With sarcoidosis, the cosmetic complaint and the disease are often the same thing. The scar, the bump around the filler, and the swollen nose may all be granulomas, and the first instrument should be a biopsy needle, not a scalpel."

• Prednisone and other steroids. Steroids slow wound healing, thin the skin, raise infection risk, raise blood sugar, and in long-term users suppress the body's own steroid production. Surgeons generally prefer patients to be on the lowest workable dose before elective surgery. Abruptly stopping steroids before surgery is dangerous, both because the disease may flare and because of adrenal crisis risk. Patients who have taken steroids for weeks or longer should tell the anesthesia team, which may give a stress dose at the time of surgery. The routine short steroid courses some surgeons use to reduce swelling, discussed in the piece on steroids for swelling after plastic surgery, need to be coordinated with whatever the patient already takes.
• Methotrexate. In rheumatic diseases, the 2022 American College of Rheumatology and American Association of Hip and Knee Surgeons guideline for joint replacement recommends continuing methotrexate through surgery, because stopping it risks a flare without a clear reduction in infection risk. Many sarcoidosis specialists apply similar logic, but the decision should be made explicitly by the prescribing doctor. Methotrexate also affects the liver, so liver tests and alcohol advice around surgery matter.
• Hydroxychloroquine. Generally continued around surgery. It requires regular eye exams for retinal toxicity, which overlap with the eye exams sarcoidosis already requires.
• TNF inhibitors and other biologics. The same joint replacement guideline recommends scheduling surgery at the end of a biologic's dosing interval, effectively holding one dose, and restarting once the wound is healing well and there is no sign of infection. Patients on infliximab for lupus pernio or cardiac disease should not stop treatment without their specialist's agreement, because flares can be serious. TNF inhibitors also call for screening for latent tuberculosis, which the patient will likely already have had.

Patients should also tell their surgeon about any history of steroid-induced diabetes, bone thinning, or cataracts, all common in people who have taken steroids for years. Steroid-thinned skin bruises and tears easily, which matters for facelifts and any procedure involving skin flaps. Smoking interacts with nearly all of these problems, and the timelines in the piece on pre-op smoking cessation apply in full.

After surgery. Beyond the usual instructions, a patient with sarcoidosis should watch for a few specific warning signs: palpitations, lightheadedness, or fainting, which could signal a rhythm problem; new shortness of breath or chest pain, which also raises the question of a blood clot, discussed in the piece on blood clots after plastic surgery; eye pain, redness, or blurred vision; and, over the following months, a scar that becomes raised, firm, and purple rather than flattening and fading. The last of these is the one most likely to be missed, because it can appear long after the surgeon has stopped seeing the patient. Patients should know to send a photograph to their dermatologist if it happens, rather than waiting for the next routine visit.

Which procedures are reasonable? In a patient whose disease is stable, with normal heart screening and acceptable lung function, many body procedures, such as liposuction, tummy tuck, or breast surgery, are reasonable in principle, with the caveat that any new scar can become a site of disease. Facial procedures in someone with a history of skin sarcoidosis deserve more caution, because the face is where skin disease concentrates. Procedures on skin with active sarcoid lesions should wait until those lesions are treated. Fillers and laser resurfacing should be approached conservatively, using dissolvable products where possible and small test areas for lasers. For people who need to camouflage disease that cannot be removed, the options in the piece on scar camouflage and medical tattooing are worth knowing about, though placing new pigment into skin with a history of tattoo sarcoidosis would be unwise. For any of these decisions, a second consultation with a surgeon or dermatologist who has managed sarcoidosis before is time well spent.

The honest summary

Sarcoidosis does not rule out cosmetic surgery or injectables, but it changes the order of operations. The disease prefers scars, tattoos, filler, and the skin of the central face, so a new bump at a filler site, an old scar that turns raised and purple, a dusky thickening of the nose, a puffy eyelid, or a widening jaw may each be sarcoidosis itself rather than a cosmetic problem, and each deserves a biopsy or a specialist's look before it is cut, dissolved, lasered, or filled. Underneath the skin, the disease can involve the lungs, the eyes, the calcium balance, and the heart, and cardiac involvement is common enough and quiet enough that anyone with sarcoidosis should have rhythm screening before an elective anesthetic. Steroids, methotrexate, and biologics all need a written plan, and long-term steroid users may need extra coverage on the day of surgery. The right time for an elective procedure is when the disease has been quiet for months and the specialist following it agrees. The right surgeon is the one who asks for that agreement in writing and knows that the incision being planned may become the next place the disease appears. The wrong one treats "sarcoidosis, in remission" as a box already checked.